Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study

被引：0
|
作者：
Maria Michela Cainazzo
Carlo Baraldi
Anna Ferrari
Flavia Lo Castro
Luca Pani
Simona Guerzoni
机构：
[1] AOU Policlinico di Modena,Medical Toxicology
[2] University of Modena and Reggio Emilia,Headache and Drug Abuse Research Center, Department of Specialized Medicine
[3] University of Modena and Reggio Emilia,Doctoral School of Neuroscience, Department of Biomedical, Metabolic and Neural Sciences
[4] University of Modena and Reggio Emilia,Medical Toxicology
[5] University of Modena and Reggio Emilia,Headache and Drug Abuse Research Center, Department of Biomedical, Metabolic and Neural Sciences
[6] University of Miami,Post
[7] VeraSci,graduated School of Pharmacology and Clinical Toxicology, Department of Biomedical, Metabolic and Neural Sciences
来源：
Neurological Sciences | 2021年 / 42卷
关键词：
Chronic migraine; Medication overuse headache; Erenumab; Headache index; Analgesic consumption;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4193 / 4202
页数：9
相关论文
共 31 条
  • [1] Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study
    Cainazzo, Maria Michela
    Baraldi, Carlo
    Ferrari, Anna
    Lo Castro, Flavia
    Pani, Luca
    Guerzoni, Simona
    NEUROLOGICAL SCIENCES, 2021, 42 (10) : 4193 - 4202
  • [2] Erenumab Discontinuation After 12-Month Treatment A Multicentric, Observational Real-Life Study
    di Cola, Francesca Schiano
    Caratozzolo, Salvatore
    Venturelli, Elisabetta
    Balducci, Ubaldo
    Sidoti, Vincenzo
    Pari, Elisa
    Costanzi, Chiara
    di Summa, Alfonsina
    Sixt, Gabriele Johanna
    D'Adda, Elisabetta
    Liberini, Paolo
    Rao, Renata
    Padovani, Alessandro
    NEUROLOGY-CLINICAL PRACTICE, 2021, 11 (06) : E834 - E839
  • [3] Effects of electroacupuncture on treatment-resistant chronic migraine with medication overuse headache: A 12-month follow-up case report
    Gao, Ning
    Wu, Lili
    Liu, Xinkun
    Lin, Zhenyu
    Liu, Zhishun
    Liang, Jun
    Wang, Weiming
    HELIYON, 2024, 10 (09)
  • [4] Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headache
    Marmura, Michael J.
    Diener, Hans-Christoph
    Cowan, Robert P.
    Tepper, Stewart J.
    Diamond, Merle L.
    Starling, Amaal J.
    Hirman, Joe
    Mehta, Lahar
    Brevig, Thomas
    Cady, Roger
    HEADACHE, 2021, 61 (09): : 1421 - 1431
  • [5] Monoclonal antibodies for chronic migraine and medication overuse headache: A real-world study
    Krymchantowski, Abouch V. V.
    Jevoux, Carla
    Krymchantowski, Ana Gabriela
    Silva-Neto, Raimundo Pereira
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [6] Erenumab and Possible CGRP Effect on Chronotype in Chronic Migraine: A Real-Life Study of 12 Months Treatment
    Pilati, Laura
    Torrente, Angelo
    Di Marco, Salvatore
    Ferlisi, Salvatore
    Notaro, Giulia
    Romano, Marika
    Alonge, Paolo
    Vassallo, Lavinia
    Ferrau, Ludovica
    Autunno, Massimo
    Grugno, Rosario
    Camarda, Cecilia
    Brighina, Filippo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (10)
  • [7] Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study
    Gladstone, Jonathan
    Chhibber, Sameer
    Minhas, Jagdeep
    Neish, Calum S.
    Power, G. Sarah
    Lan, Zhiyi
    Rochdi, Driss
    Lanthier-Martel, Jessica
    Bastien, Natacha
    HEADACHE, 2022, 62 (01): : 78 - 88
  • [8] Medication Overuse Headache, Chronic Migraine and Monoclonal Antibodies Anti-CGRP: A Real-World Study
    Krymchantowski, Abouch
    Jevoux, Carla
    Krymchantowski, Ana Gabriela
    Silva-Neto, Raimundo Pereira
    CLINICAL NEUROPHARMACOLOGY, 2023, 46 (05) : 181 - 185
  • [9] Galcanezumab for the treatment of chronic migraine and medication overuse headache: Real-world clinical evidence in a severely impaired patient population
    Guerzoni, Simona
    Baraldi, Carlo
    Castro, Flavia Lo
    Cainazzo, Maria Michela
    Pani, Luca
    BRAIN AND BEHAVIOR, 2023, 13 (06):
  • [10] Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study
    Barbanti, Piero
    Aurilia, Cinzia
    Egeo, Gabriella
    Fofi, Luisa
    Cevoli, Sabina
    Colombo, Bruno
    Filippi, Massimo
    Frediani, Fabio
    Bono, Francesco
    Grazzi, Licia
    Salerno, Antonio
    Mercuri, Bruno
    Carnevale, Antonio
    Altamura, Claudia
    Vernieri, Fabrizio
    HEADACHE, 2021, 61 (02): : 363 - 372
1234